Wolverine Trading’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.9K | Buy |
61,165
+25,493
| +71% | +$32.9K | ﹤0.01% | 1093 |
|
|
2025
Q1 | $40.7K | Buy |
35,672
+19,957
| +127% | +$22.8K | ﹤0.01% | 1225 |
|
|
2024
Q4 | $28.1K | Buy |
15,715
+3,718
| +31% | +$6.66K | ﹤0.01% | 1448 |
|
|
2024
Q3 | $21K | Sell |
11,997
-6,403
| -35% | -$11.2K | ﹤0.01% | 1262 |
|
|
2024
Q2 | $25.2K | Buy |
18,400
+4,205
| +30% | +$5.76K | ﹤0.01% | 1186 |
|
|
2024
Q1 | $53.2K | Buy |
+14,195
| New | +$53.2K | ﹤0.01% | 1102 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1906 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1867 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1832 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1809 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1817 |
|
|
2018
Q4 | – | Sell |
-28,152
| Closed | -$152K | – | 1847 |
|
|
2018
Q3 | $152K | Buy |
+28,152
| New | +$152K | ﹤0.01% | 1307 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1952 |
|
|
2017
Q3 | – | Sell |
-14,157
| Closed | -$53K | – | 1750 |
|
|
2017
Q2 | $53K | Sell |
14,157
-3,356
| -19% | -$12.6K | ﹤0.01% | 1171 |
|
|
2017
Q1 | $91K | Buy |
+17,513
| New | +$91K | ﹤0.01% | 1091 |
|
|
2016
Q4 | – | Sell |
-16,790
| Closed | -$148K | – | 1787 |
|
|
2016
Q3 | $148K | Sell |
16,790
-17,151
| -51% | -$151K | ﹤0.01% | 910 |
|
|
2016
Q2 | $250K | Buy |
+33,941
| New | +$250K | ﹤0.01% | 612 |
|